Published January 1, 2021
| Version v1
Journal article
Open
Effects of Different Tacrolimus Doses on Adipose-Derived Stem Cells
- 1. Akdeniz Univ, Sch Med, Dept Plast Reconstruct & Anesthet Surg, Antalya, Turkey
Description
Objectives: Tacrolimus is currently one of the most commonly used immunosuppressant agents to prevent rejection in organ transplant. Although modern immunosuppressive agents have been successful, rejection cannot be completely prevented. Therefore, in organ transplant research, additional treatment methods are being investigated, with the most important one being stem cell therapy. In addition to tacrolimus therapy, stem cell therapy is now clinically applicable, with frequency of concomitant use seeming to expand in the future. In this study, the effects of tacrolimus on stem cells were investigated.
Files
bib-37c9fbf1-c323-4edc-af1b-7b69f1a83150.txt
Files
(170 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:ce4cba66afe68d16417a4813d082ebe1
|
170 Bytes | Preview Download |